Common-Size Income Statement
Paying user area
Try for free
Celgene Corp. pages available for free this week:
- Balance Sheet: Assets
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Analysis of Geographic Areas
- Capital Asset Pricing Model (CAPM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Return on Equity (ROE) since 2005
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Celgene Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31).
Income statement item | Description | The company |
---|---|---|
Operating income | The net result for the period of deducting operating expenses from operating revenues. | Celgene Corp. operating income as a percentage of net product sales increased from 2016 to 2017 but then slightly decreased from 2017 to 2018. |
Income before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Celgene Corp. income before income taxes as a percentage of net product sales increased from 2016 to 2017 but then slightly decreased from 2017 to 2018. |
Net income | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Celgene Corp. net income as a percentage of net product sales increased from 2016 to 2017 and from 2017 to 2018. |